Heparin‐Coated Equipment Reduces Complement Activation during Cardiopulmonary Bypass in the Pig
- 1 February 1990
- journal article
- research article
- Published by Wiley in Artificial Organs
- Vol. 14 (1) , 46-48
- https://doi.org/10.1111/j.1525-1594.1990.tb01591.x
Abstract
Complement activation was studied during cardiopulmonary bypass (CPB) in the pig. One group of animals was perfused for 2 h using a standard extracorporeal circuit includig a hollow fiber membrane oxygenator with full systemic heparinization. Another group was treated in the same way, except that bypass was performed through a heparin-coated CPB circuit (Carmeda Bio-Active Surface, CBAS) and systemic heparinization was reduced by 75%. It was found that complement activation during CPB, measured as changes in the ratio C3d/C3, was significantly less in the CBAS group, most probably reflecting a better biocompatibility.Keywords
This publication has 10 references indexed in Scilit:
- Activation of inflammatory systems during cardiopulmonary bypassScandinavian Journal of Thoracic and Cardiovascular Surgery, 1988
- Treatment of Acute Respiratory Failure by Extracorporeal Carbon Dioxide Elimination Performed with a Surface Heparinized Artificial LungAnesthesiology, 1987
- Extracorporeal Elimination of Carbon Dioxide Using a Surface-Heparinized Veno-Venous Bypass SystemAnnual Northeast Bioengineering Conference, 1986
- Deleterious effects of cardiopulmonary bypassThe Journal of Thoracic and Cardiovascular Surgery, 1985
- Plasma C3d/C3 quotient as a parameter for in vivo complement activationJournal of Immunological Methods, 1984
- Complement and the damaging effects of cardiopulmonary bypassThe Journal of Thoracic and Cardiovascular Surgery, 1983
- A New Non-Thrombogenic Surface Prepared by Selective Covalent Binding of Heparin Via a Modified Reducing Terminal ResidueBiomaterials, Medical Devices, and Artificial Organs, 1983
- Complement Activation during Cardiopulmonary BypassNew England Journal of Medicine, 1981
- HUMAN ALTERNATIVE COMPLEMENT PATHWAY - MEMBRANE-ASSOCIATED SIALIC-ACID REGULATES THE COMPETITION BETWEEN B AND BETA-1H FOR CELL-BOUND C3B1979
- Human Alternative Complement Pathway: Membrane-Associated Sialic Acid Regulates the Competition between B and β1H for Cell-Bound C3bThe Journal of Immunology, 1979